Platycodin D Reduces PD-L1 Levels by Inhibiting LXR-β Activity and Combines with Nintedanib to Enhance the Tumor-Killing Effect of T Cells
FEBS letters（2024）
Key words
cancer therapy,cholesterol,immunotherapy,MHC,PD-L1,platycodin D
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined